| Volume 17, 2013 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: How Many Pharmacies Compound and What Do They Compound?
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 4
|
PreScription: Looking for Solutions
Menighan Thomas E
|
Jan/Feb 2013
Pg. 4
|
Pediatric Health Care: An Introduction
Williams LaVonn A
|
Jan/Feb 2013
Pg. 6-8
|
Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients
Zur Eyal
|
Jan/Feb 2013
Pg. 10-22
|
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Wung Deanna
|
Jan/Feb 2013
Pg. 24-27
|
Treatment Options for Male Hypogonadism
Biundo Bruce
|
Jan/Feb 2013
Pg. 28-38
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
International Academy of Compounding Pharmacists' Recommendations for State-based Legislative and Regulatory Initiatives
Miller David G
|
Jan/Feb 2013
Pg. 48-49
|
Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 50-53
|
Basics of Compounding: Repackaging, Part 1
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 54-60
|
Calculations
Stockton Shelly J
|
Jan/Feb 2013
Pg. 62-63
|
Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 64
|
Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 65
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 67
|
Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 68
|
Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 69
|
Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 70
|
Nicardipine Hydrochloride Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 71
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
|
Jan/Feb 2013
Pg. 74-85
View Sample |
Errata
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 86
|
PostScription: GMPs and GCPs: A Topical Comparison
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 87
|
PreScription: Pharmacy Committees
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 92
|
Sterilization of Compounded Parenteral Products: Verification of Autoclaves
Rahe Hank
|
Mar/Apr 2013
Pg. 94-98
|
Intravenous Needle-free Injection Devices: New Information for Compounding Pharmacists
Macklin Denise, Blackburn Paul L
|
Mar/Apr 2013
Pg. 100-110
|
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
|
Mar/Apr 2013
Pg. 113-123
|
Compounding in Ukraine
Zdoryk Oleksandr A, Georgiyants Victoriya A, Gryzodub Oleksandr I, Schnatz Rick
|
Mar/Apr 2013
Pg. 124-127
|
International Academy of Compounding Pharmacists Legislative/Regulatory Update
Miller David G
|
Mar/Apr 2013
Pg. 128
|
Quality Control Analytical Methods: Strategies to Ensure a Robust Quality-control Microbiology Program
Griffiths Tricia, Connors Anne
|
Mar/Apr 2013
Pg. 130-134
|
Basics of Compounding: Repackaging, Part 2
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 136-140
|
Calculations
Stockton Shelly J
|
Mar/Apr 2013
Pg. 142
|
Adenosine 3-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 144
|
Alcohol Dehydrated Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 145
|
Betahistine 16-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 146
|
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 147
|
Cyanocobalamin 1000-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 148
|
Dexrazoxane 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 149
|
Meropenem 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 150
|
Paclitaxel 6-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 151
|
Thiotepa 15-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 152
|
Verapamil Hydrochloride 2.5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 153
|
Compounding Practices and Beliefs of Arizona Pharmacists
Cauthon Kimberly AB, Bowman Bill J, Gurney Mary K
|
Mar/Apr 2013
Pg. 154-161
|
Stability of Rifampin in SyrSpend SF
Sorenson Bridget, Whaley Paul
|
Mar/Apr 2013
Pg. 162-164
|
Stability of Minoxidil in Espumil Foam Base
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Mar/Apr 2013
Pg. 165-167
|
Establishing Benchmark Rates of Microbial and Bacterial Endotoxin Contamination for Radiopharmaceuticals Compounded in Commerical Nuclear Pharmacy Settings
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
Mar/Apr 2013
Pg. 168-174
|
PreScription: Compounding for Drug Shortages
Allen Loyd V Jr
|
May/Jun 2013
Pg. 180
|
Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists
Mixon Bill, Nain John
|
May/Jun 2013
Pg. 182-190
|
Decontamination Technology: The Missing Element
Rahe Hank
|
May/Jun 2013
Pg. 193-199
|
Optimizing Third-party Reimbursement for Compounded Medications
McElhiney Linda F
|
May/Jun 2013
Pg. 201-204
|
International Academy of Compounding Pharmacists' Legislative/Regulatory Update
Miller David G
|
May/Jun 2013
Pg. 206
|
Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations
Allen Loyd V Jr
|
May/Jun 2013
Pg. 210-219
|
Basics of Compounding: Potency and Stability Testing
Allen Loyd V Jr
|
May/Jun 2013
Pg. 220-224
|
Calculations
Stockton Shelly J
|
May/Jun 2013
Pg. 226
|
Buffered Aspirin Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 228
|
Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 229
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Ethambutol 400-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 231
|
Isoniazid 300-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 232
|
Labetalol 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 233
|
Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 234
|
Naltrexone Hydrochloride 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 235
|
Prednisone 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 236
|
Reserpine 0.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 237
|
Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines
Weatherman Kara D, Augustine Samuel, Christoff Jeffrey, Galbraith Wendy
|
May/Jun 2013
Pg. 238-246
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja, Krämer Irene, Kamin Wolfgang
|
May/Jun 2013
Pg. 254-261
|
PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial
Williams LaVonn A
|
May/Jun 2013
Pg. 262-263
|
Prescription: International Journal of Pharmaceutical Compounding and MEDLINE Update
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 268
|
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A, Stout Richard R, Ron Marcinkoski
|
Jul/Aug 2013
Pg. 270-280
|
United States Pharmacopeia Chapter <797> Timeline: 1989 to 2013
Newton David W
|
Jul/Aug 2013
Pg. 283-288
|
Pharmacists' Liability: What My Pharmacy Law Professor Did Not Cover
Rizo Mike
|
Jul/Aug 2013
Pg. 290-293
|
Types of Pharmacy/Pharmacists
Williams LaVonn A
|
Jul/Aug 2013
Pg. 294-301
|
International Academy of Compounding Pharmacists Legislative/Regulatory Update
Miller David G
|
Jul/Aug 2013
Pg. 302-304
|
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations
McElhiney Linda F
|
Jul/Aug 2013
Pg. 307-311
|
Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 312-322
|
Calculations
Stockton Shelly J
|
Jul/Aug 2013
Pg. 324
|
Acyclovir 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 326
|
Acyclovir 200-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 327
|
Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 328
|
Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 329
|
Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 330
|
Ketamine 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 331
|
Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 332
|
Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 333
|
Rifampin 300-mg and Isoniazid 150-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 334
|
Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 335
|
Stability of Captopril in SyrSPend SF
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013
Pg. 336-338
|
Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B, Fontane Patrick E, Day Jonathan R
|
Jul/Aug 2013
Pg. 339-343
|
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Geiger Christine M, Sorenson Bridget, Whaley Paul A
|
Jul/Aug 2013
Pg. 344-346
|
Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs
Boonme Prapaporn, Maneenuan Duangkhae, Channarong Sunee
|
Jul/Aug 2013
Pg. 347-350
|
PostScription: Traditional vs Nontraditional Pharmacy
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 351
|
PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 356
|
Compounding Pharmacies: Before and After an Inspection
Kulkarni Darshan, Ricketts Samantha
|
Sep/Oct 2013
Pg. 358-362
|
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
|
Sep/Oct 2013
Pg. 364-368
|
Chemical Penetration Enhancers
Newton Stephen J
|
Sep/Oct 2013
Pg. 370-374
|
2013 State Compounding Legislation Tracker Updated: August 12, 2013
Miller David G
|
Sep/Oct 2013
Pg. 375-378
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines
Pruitt Bobby N III
|
Sep/Oct 2013
Pg. 384-387
|
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1
Horace Alexis E, Akbarian-Tefagh Jessica
|
Sep/Oct 2013
Pg. 388-391
|
Quality Control Analytic Methods: Quality Planning, Part 1: A Holistic and Practical Approach
Odegard Russell D
|
Sep/Oct 2013
Pg. 393-399
|
Basics of Compounding: Basics of Compounding with Tars
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 400-410
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
Sep/Oct 2013
Pg. 412
|
Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 414
|
Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 415
|
Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 416
|
Fluorouracil 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 417
|
Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 418
|
Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 419
|
Mesna 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 420
|
Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 421
|
Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 422
|
Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 423
|
In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs
Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
|
Sep/Oct 2013
Pg. 424-431
|
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment
Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
|
Sep/Oct 2013
Pg. 432-435
|
Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration
Ramaley Corrine C, Li Feng, Du Chengan
|
Sep/Oct 2013
Pg. 436-438
|
PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 439
|
PreScription: Two Milestones for the International Journal of Pharmaceutical Compounding
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 444
|
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2
Horace Alexis E, Akbarian-Tefagh Jessica
|
Nov/Dec 2013
Pg. 446-450
|
Clinical Utility of Pharmacogenetic Testing in Compounding Pharmacy
Fichter Brian, Heintzelman Tom, Hurst Sawan, Fitzsimmons Dorothy, Mailloux Christina
|
Nov/Dec 2013
Pg. 452-457
|
Considerations for Pharmacists Working in Major Disaster Areas
Kawataba Yoshinori
|
Nov/Dec 2013
Pg. 459-463
|
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies
Brensel Robert, Brensel Scott, Ng Amy
|
Nov/Dec 2013
Pg. 465-475
|
Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 477-479
|
HR 3204 -- The Drug Quality and Security Act: What Does It Say? What Does It Mean? What Happens Now?
Miller David G
|
Nov/Dec 2013
Pg. 480-481
|
Marketing During the Holidays
Moore Renee
|
Nov/Dec 2013
Pg. 482-483
|
Quality Control Analytical Methods: A Growing Codependency: Compounding Pharmacy and Safety
Prince Bryan, Lundeval Jeremy
|
Nov/Dec 2013
Pg. 485-489
|
Basics of Compounding: Basics of Compounding with Balsams
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 490-495
|
Calculations
Stockton Shelly J
|
Nov/Dec 2013
Pg. 496
|
Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 498
|
Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 499
|
Ciprofloxacin 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 500
|
Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 501
|
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 502
|
Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 503
|
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 504
|
Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 505
|
Metyrosine 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 506
|
Phenytoin Sodium 50-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 507
|
Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles
McPherson Timothy B, Neumann William L, Kolling William M
|
Nov/Dec 2013
Pg. 508-511
|
Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds
Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
|
Nov/Dec 2013
Pg. 512-514
|
Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes
McCluskey Susan V, Vu Nicole, Rueter John
|
Nov/Dec 2013
Pg. 515-519
|
Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream
Wang Xuexuan, Black Laura
|
Nov/Dec 2013
Pg. 520-525
|
PostScription: Augmented Reality for Readers and Authors
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 526-527
|
